Abstract 226P
Background
Urothelial carcinoma (UC) has a highly complex genomic landscape. With the spread of immunotherapy, accurate stratification strategies are needed. As cancer tissues are now frequently screened for specific sets of mutations, a large number of samples has become available for analysis. Classification of patients with similar mutation profiles may help identifying subgroups of patients outcomes. However, classification based on somatic mutations is challenging due to the sparseness and heterogeneity of the data.
Methods
A retrospective study was performed to identify the prognosis-related somatic mutations from 192 UC in The Cancer Genome Atlas (TCGA) database. Cox regression were performed to screen out prognostic genes.
Results
A total of 176 genes were related with immuno-survival. Then, a stepwise multivariate Cox regression analysis was performed, and 14 gene were selected to establish a predictive model. Compared with the wildtype group, the patients with mutated signature had unfavorable to prognosis (p<0.001). ROC curve analysis demonstrated the predictive ability for 1-, 3-, 5-, and 10-year OS, with areas under the curve (AUCs) of 0.7684, 0.667,0.619 and 0.647, respectively. In mutated signature cohorts, the five most frequently mutated genes were TP53 (50%), KMT2D (43%), LRP1B (33%), PER1 (33%), and RNF213 (33%). Dissimilarly, the five most frequently mutated genes were TP53 58%), ARID1A (29%), KMT2D (29%), RNF213 (27%), and KDM6A (26%) in wildtype cohorts, which may imply that different characteristic states have different molecular mechanisms.
Conclusions
These data underline the potential value of using somatic mutations to accurately stratify UC patients into clinically actionable subgroups. This model could reduce overtreatment in UC patients with mutations.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
101P - The coexistence of TP53 gain-of-function mutation and hypermethylation as a poor prognostic factor in BRAF wild-type metastatic colorectal cancer
Presenter: Kota Ouchi
Session: Poster Display
Resources:
Abstract
102P - Enhancing colorectal cancer prevention in high-risk populations through faecal immunochemical test surveillance
Presenter: Li Xie
Session: Poster Display
Resources:
Abstract
103P - Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: Updated results from a multi-cohort, multi-center phase II trial ALTER-G-001-cohort A
Presenter: Junwei Wu
Session: Poster Display
Resources:
Abstract
104P - The value of functional MR-imaging signature model for early prediction of chemotherapy response and its guidance for regimen adjustment to improve efficacy
Presenter: Wenhua Li
Session: Poster Display
Resources:
Abstract
105P - A single-arm, phase II, multicenter study of iparomlimab (QL1604) in patients (pts) with unresectable/metastatic deficient mismatch repair (dMMR)/microsatellite instability high (MSI-H) solid tumors
Presenter: Weijian Guo
Session: Poster Display
Resources:
Abstract
106P - Efficacy and safety of IBI351 (GFH925) monotherapy in metastatic colorectal cancer harboring KRASG12C mutation: Updated results from a pooled analysis of two phase I studies
Presenter: Ying Yuan
Session: Poster Display
Resources:
Abstract
107P - Tumor-stromal ratio in a new age fibroblast activated protein PET imaging as a biomarker for prediction of response to neoadjuvant chemoradiotherapy in carcinoma rectum
Presenter: swetha Suresh
Session: Poster Display
Resources:
Abstract
108P - Detection of HER2 overexpression in colorectal cancer: Comparison of a HANDLE classic NGS panel with standard IHC/FISH
Presenter: Lijuan Luan
Session: Poster Display
Resources:
Abstract
109P - Early onset metastatic colorectal cancer: Clinical-prognostic characteristics and correlation to molecular status
Presenter: Andrea Pretta
Session: Poster Display
Resources:
Abstract
110P - The correlation between multi-dimensional characteristics of circulating tumor cells (CTC) and treatment response in patients with initially unresectable metastatic colorectal cancer
Presenter: Yu Liu
Session: Poster Display
Resources:
Abstract